Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
11/2003
11/26/2003CN1128791C Substituted acylamino phenyl uracils compounds
11/26/2003CN1128790C 4-hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents
11/26/2003CN1128617C Preparation method for medicinal composition containing triazolyl derivative
11/25/2003US6653478 Substituted benzimidazol-2-ones as vasopressin receptor antagonists and neuropeptide Y modulators
11/25/2003US6653338 FSH mimetics for the treatment of infertility
11/25/2003US6653330 Amide-type triazole compounds
11/25/2003US6653326 Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof
11/25/2003US6653307 1-aryl-4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents
11/25/2003US6653306 Epoxy-steroidal aldosterone antagonist and angiotensin II antagonist combination therapy
11/25/2003US6653305 For therapy of tumoral diseases, diseases of the lungs and respiratory tract
11/25/2003US6653304 Antiarthritic agents; skin disorders; anticarcinogenic agents
11/25/2003US6653302 Quinoline and quinazoline compounds useful in therapy
11/25/2003US6653301 For therapy of cancer, diabetes and Alzheimer's disease
11/25/2003US6653300 Pyrazole compounds useful as protein kinase inhibitors
11/25/2003US6653296 Antiretroviral enantiomeric nucleotide analogs
11/25/2003US6653086 Fusion protein; ligand has not been identified; screening for agonists/ antagonists
11/24/2003CA2387644A1 1,3-oxazolium-5-oxides or their alpha-amidoketene tautomers, process of preparation and uses thereof
11/20/2003WO2003095982A1 Wavy interface mixer
11/20/2003WO2003095449A1 Small molecules for inhibition of function and drug delivery to leukocytes
11/20/2003WO2003095447A1 Process for the preparation of a hydrate of an anthranilic acid derivative
11/20/2003WO2003095441A1 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same
11/20/2003WO2003095440A1 Dihydroxyhexanoic acid derivatives, their intermediates, and methods of making
11/20/2003WO2003095438A1 Substituted phenylacetamides and their use as glucokinase activators
11/20/2003WO2003095433A1 Hexahydro-pyridazine-3-carboxylic acid derivatives, pharmaceutical compositions containing same and preparation methods thereof
11/20/2003WO2003095432A1 Benzimidazole derivatives
11/20/2003WO2003095430A1 Substituted pyrazolyl compounds for the treatment of inflammation
11/20/2003WO2003094918A1 Substituted piperazine as melanocortin receptors ligands
11/20/2003WO2003094845A2 Pyridine-based thyroid receptor ligands
11/20/2003WO2003051276A3 Therapeutic heterocycles
11/20/2003WO2003048130A3 Peroxisome proliferator activated receptor agonists
11/20/2003WO2003032984A8 2-phenyl benzimidazoles and imidazo-[4,5]-pyridines as cdsi/chk2-inhibitors and adjuvants to chemotherapy or radiation therapy in the treatment of cancer
11/20/2003WO2003029210A3 Heteroaryl substituted tetrazole modulators of metabotropic glutamate receptor-5
11/20/2003WO2003027076A3 1h-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1- antagonistic activity
11/20/2003WO2003014105A9 Bicyclic compound, production and use as hiv inhibitors
11/20/2003WO2003006447A3 Interaction inhibitors of tcf-4 with beta-catenin
11/20/2003WO2002041910A3 Methods and compositions for the treatment of diseases of the eye
11/20/2003WO2002032869A8 Substituted heterocyclic compounds for treating multidrug resistance
11/20/2003US20030216586 Biaromatic compounds and pharmaceutical and cosmetic compositions comprising them
11/20/2003US20030216575 Novel pyranosyl cytosines: pharmaceutical formulations and methods
11/20/2003US20030216571 Tricyclic compounds
11/20/2003US20030216451 Polycyclic aryl and heteroaryl substituted 4-pyrones useful for selective inhibition of the coagulation cascade
11/20/2003US20030216450 Inhibitors of dipeptidyl peptidase IV
11/20/2003US20030216437 Thrombin receptor antagonists
11/20/2003US20030216433 Gastrointestinal disorders; serotonine receptor antagonist; side effect reduction
11/20/2003US20030216429 7-Heterocyclyl quinoline and thieno[2,3-b]pyridine derivatives useful as antagonists of gonadotropin releasing hormone
11/20/2003US20030216417 Substituted anilino-quinoline compounds and use thereof
11/20/2003US20030216408 -4-substituted-N-(2-(4-(2,3-dihydro-benzo(1,4)dioxin-5-yl)-piperazin -1-yl)propy l)-N-pyridin-2-yl-benzamide or salt; useful as 5-HT1A receptor antagonists
11/20/2003US20030216406 Pyrimidine derivatives
11/20/2003US20030216404 Hydroxamic acid derivatives
11/20/2003US20030216385 Triazole derivatives
11/20/2003US20030216383 Compounds useful as reversible inhibitors of cysteine proteases
11/20/2003US20030216382 Useful for the treatment and/or prophylaxis of diseases associated with dipeptidyl peptidase, such as diabetes, particularly non-insulin dependent diabetes mellitus, and impaired glucose tolerance
11/20/2003US20030216380 Novel gamma secretase inhibitors
11/20/2003US20030216258 Condensed heterocylic compounds and herbicides containing them as active ingredients
11/20/2003US20030215667 Electroluminescent devices
11/20/2003US20030213164 Substituted 5-aryl-2-(2-hydroxyphenyl)-2H-benzotriazole UV absorbers, compositions stabilized therewith and process for preparation thereof
11/20/2003US20030213071 Comprises mixing 5-(2,4-dimethoxyphenyl)-1,3,3-trimethyl-2-methylene-indoline and carbonyl compound (4-hydroxy-3-methoxy-benzaldehyde) for dyeing keratin fibers (wool, silk, and/or hair)
11/20/2003CA2485753A1 Benzimidazole derivatives
11/20/2003CA2485083A1 Hexahydro-pyridazine-3-carboxylic acid derivatives, pharmaceutical compositions containing same and preparation methods thereof
11/20/2003CA2484968A1 Substituted piperazine as melanocortin receptors ligands
11/20/2003CA2484860A1 Dihydroxyhexanoic acid derivatives, their intermediates, and methods of making
11/19/2003EP1362857A1 (S)-4-amino-5-chloro-2-methoxy-n-[1-[1-(2-tetrahydrofuryl-carbonyl)-4-piperidinymethyl]-4-piperidinyl]benzamide for treating gastrointestinal motility disorders
11/19/2003EP1362856A1 Water-soluble triazole fungicide
11/19/2003EP1362855A1 Beta-lactam compounds, process for repoducing the same and serum cholesterol-lowering agents containing the same
11/19/2003EP1362850A1 Oxime ether compound and agricultural or horticultural bactericide
11/19/2003EP1362839A2 Liquid crystal composition having a delta-epsilon- of not less than zero and liquid crystal display device
11/19/2003EP1362047A2 Indazolyl-substituted pyrroline compounds as kinase inhibitors
11/19/2003EP1362046A1 Substituted pyrimidinone derivatives as ligands of integrin receptors
11/19/2003EP1362044A1 Phthalazinone-piperidino-derivatives as pde4 inhibitors
11/19/2003EP1362042A1 Cyclic 2-carbonylaminoketones as inhibitors of cruzipain and other cysteine proteases
11/19/2003EP1362039A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
11/19/2003EP1362033A1 Pyridine matrix metalloproteinase inhibitors
11/19/2003EP1362032A2 Process of preparing paroxetine and intermediates for use therein
11/19/2003EP1361879A1 2,4-disubstituted pyrimidine-5-carboxamide derivatives as kcnq potassium channel modulators
11/19/2003EP1361873A2 Matrix metalloproteinase inhibitors
11/19/2003EP1240141B1 New modulators of dopamine neurotransmission
11/19/2003EP1220848B1 N-arymethylthioanilide compounds useful for the inhibition of the replication of hiv
11/19/2003EP0973392B1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds
11/19/2003EP0809499B1 Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine
11/19/2003EP0756477B1 Methods for phototherapeutic treatment of proliferative skin diseases
11/19/2003CN1457339A Chemokine receptor binding heterocyclic compounds
11/19/2003CN1456556A Di (5-formylfurfuryl) ether derivatives, preparations thereof and their uses in medicines
11/19/2003CN1128147C 3-oxo-2(H)-1,2,4-triazine deriatives as ligands of 5HT1A receptors
11/19/2003CN1128144C Indane-1-alcohol compound, its preparation method and medical composition containing same
11/19/2003CN1128142C Novel substituted dipolymer compounds, prepn. method therefor, pharmaceutical compositions contg. same
11/19/2003CN1127955C Medicine for treating immune relative disease of anterior chamber and surface of eye
11/18/2003US6649770 Exhibit superior hydrolytic stability, handling and storage stability as well as good resistance to extractability when present in stabilized composition
11/18/2003US6649769 For labelling a polynucleotides
11/18/2003US6649656 Anticarcinogenic, antiallergen, antishock, and antiasthmatic agents
11/18/2003US6649643 Imidazol-4-ylmehanols and their use as inhibitors of steroid C17-20 lyase
11/18/2003US6649642 Succinate derivative compounds useful as cysteine protease inhibitors
11/18/2003US6649636 Cyclooxygenase inhibitors
11/18/2003US6649633 Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes
11/18/2003US6649627 N-Substituted with 1- (pyrid-2-yl)-piperidine-4-yl radical; gastrointestinal and psychological disorder treatment; antidiabetic tocolytic, and antidepressant agents; irritable bowel syndrome, glaucoma and dysmenorrhoea
11/18/2003US6649626 Stimulants of gamma -aminobutyric acid receptors; psychological disorders
11/18/2003US6649624 Useful as neuropeptide Y receptor antagonists and as agents for therapy of cardiovascular disorders, central nervous system disorders, metabolic diseases
11/18/2003US6649622 Treating diabetes, especially Type II diabetes
11/18/2003US6649620 Quinoline and quinazoline compounds useful in therapy
11/18/2003US6649618 Substituted amidoalkyl-uracils and their use
11/18/2003US6649611 Potent and selective inhibitors of chemokine binding to its receptor CCR1 found on inflammatory and immunomodulatory cells (preferably leukocytes and lymphocytes).
1 ... 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 ... 694